Nope. NVIV mainly uses hardware to address specific spinal injury; STEM is trying to build a case for the efficacy of stem cells, which to date haven't been very successful in late stage trials. STEM is a bounce play for me. Any meaningful results are too far into the future.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.